
Onesource Specialty Pharma Ltd share price
NSE: ONESOURCE · Healthcare
₹1,612.70 +0.16%
Closing price data, updated 17 Nov 2026. 52-week range: -15.9% from high, +52.6% above low.
Price₹1,612.70
Market cap₹18,493 Cr
P/E–
P/B3.12
ROE-1.3%
ROCE0.3%
Debt / equity0.26
Dividend yield0.00%
EPS₹-0.14
Book value₹516.32
Operating margin-0.4%
Dipscan score24 / 100
Share: WhatsAppX / TwitterTelegram
Onesource Specialty Pharma Ltd shareholding pattern
As of Sep 2026: Promoters 30.47%, FIIs 19.46%, DIIs 24.21%, Government 0.00%, Public 11.23%, Others 14.64%.
| Holder | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|---|
| Promoters | 30.47% | 30.48% | 30.48% | 29.93% | 29.77% | 29.79% |
| FIIs | 19.46% | 19.19% | 17.50% | 19.24% | 19.39% | 18.69% |
| DIIs | 24.21% | 23.38% | 20.61% | 18.81% | 18.49% | 18.10% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 11.23% | 11.29% | 12.18% | 12.39% | 12.42% | 13.25% |
| Others | 14.64% | 15.65% | 19.23% | 19.63% | 19.93% | 20.17% |
| No. of Shareholders | 79,770 | 77,899 | 79,460 | 84,595 | 87,416 | 87,760 |
As filed by the company with the exchanges.
Returns
| 1 day | 1 week | 1 month | 3 months | 6 months | 1 year |
|---|---|---|---|---|---|
| +0.16% | +0.81% | +11.81% | +2.63% | -11.39% | -7.96% |
Growth
| Sales growth, 3 years | +232.4% |
| Sales growth, 5 years | – |
| Profit growth, 3 years | – |
| Profit growth, 5 years | – |
| Latest quarter sales vs last year | +37.4% |
| Latest quarter profit vs last year | +448.2% |
Strengths and weaknesses
Weaknesses
- Stock is trading at 3.12 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of -2.63% over last 3 years.
- Promoters have pledged 38.8% of their holding.
- Company has high debtors of 177 days.
Peers in Healthcare
| Company | Price | Market cap | P/E | ROE | 1 year |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | ₹1,867.50 | ₹4,48,076 Cr | 40.9 | 14.7% | +8.8% |
| Divi's Laboratories Ltd. | ₹11,080.00 | ₹2,94,139 Cr | 87.5 | 16.2% | +69.4% |
| Torrent Pharmaceuticals Ltd. | ₹4,691.20 | ₹1,78,438 Cr | 84.0 | 27.1% | +22.6% |
| Apollo Hospitals Enterprise Lt | ₹8,771.00 | ₹1,26,114 Cr | 56.2 | 21.9% | +16.9% |
| Laurus Labs Ltd. | ₹2,220.00 | ₹1,19,949 Cr | 89.5 | 18.2% | +125.2% |
| Zydus Lifesciences Ltd. | ₹1,192.00 | ₹1,18,902 Cr | 28.4 | 19.7% | +27.0% |
| Dr. Reddy's Laboratories Ltd. | ₹1,377.90 | ₹1,14,778 Cr | 41.0 | 12.1% | +13.7% |
| Cipla Ltd. | ₹1,394.50 | ₹1,12,658 Cr | 38.9 | 11.8% | -8.0% |
Frequently asked questions
What is the share price of Onesource Specialty Pharma Ltd?
Onesource Specialty Pharma Ltd (ONESOURCE) last closed at ₹1,612.70 (+0.16% on the day).
What is the market cap of Onesource Specialty Pharma Ltd?
About ₹18,493 Cr.
What is the P/E ratio of Onesource Specialty Pharma Ltd?
The price-to-earnings ratio is –, and return on equity is -1.3%.
Figures are calculated from company results and exchange prices and are for information only.